| # | Drug | Count |
|---|---|---|
| 0 | VALPROATE SODIUM | 11 |
| 1 | FOLIC ACID | 9 |
| 2 | PREDNISONE | 4 |
| 3 | DUPILUMAB | 2 |
| 4 | ESCITALOPRAM | 2 |
| 5 | GABAPENTIN | 2 |
| 6 | LEVETIRACETAM | 2 |
| 7 | NIRSEVIMAB | 2 |
| 8 | RITUXIMAB | 2 |
| 9 | SIROLIMUS | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0058 |
| 1 | L-LYSINE | 1 | 0.0014 |
| 2 | NIRSEVIMAB | 2 | 0.0011 |
| 3 | VALPROATE SODIUM | 11 | 0.0005 |
| 4 | IPRATROPIUM BROMIDE AND ALBUTEROL | 1 | 0.0004 |
| 5 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 6 | SIROLIMUS | 2 | 0.0001 |
| 7 | TROFINETIDE | 1 | 0.0001 |
| 8 | TERAZOSIN HYDROCHLORIDE | 1 | 0.0001 |
| 9 | MISOPROSTOL | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vitamin C [EPC] | 11 |
| 1 | Vitamin B12 [EPC] | 10 |
| 2 | Vitamin D [EPC] | 10 |
| 3 | Corticosteroid [EPC] | 4 |
| 4 | Benzodiazepine [EPC] | 3 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 2 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2 |
| 7 | Kinase Inhibitor [EPC] | 2 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 9 | Opioid Agonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |
| 1 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 2 | Barbiturate [EPC] | 1 | 0.0001 |
| 3 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 4 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Hemoglobin S Polymerization Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Vitamin D [EPC] | 10 | 0.0000 |